Cargando…
LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
LSD1, a lysine-specific histone demethylase, is overexpressed in several types of cancers and linked to poor outcomes. In breast cancer, the significance of LSD1 overexpression is not clear. We have performed an in silico analysis to assess the relationship of LSD1 expression to clinical outcome. We...
Autores principales: | Nagasawa, Satoi, Sedukhina, Anna S., Nakagawa, Yuko, Maeda, Ichiro, Kubota, Manabu, Ohnuma, Shigeko, Tsugawa, Koichiro, Ohta, Tomohiko, Roche-Molina, Marta, Bernal, Juan A., Narváez, Ana J., Jeyasekharan, Anand D., Sato, Ko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332491/ https://www.ncbi.nlm.nih.gov/pubmed/25679396 http://dx.doi.org/10.1371/journal.pone.0118002 |
Ejemplares similares
-
NF-κB signaling mediates acquired resistance after PARP inhibition
por: Nakagawa, Yuko, et al.
Publicado: (2015) -
MED12 exon 2 mutations in phyllodes tumors of the breast
por: Nagasawa, Satoi, et al.
Publicado: (2015) -
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast
por: Nagasawa, Satoi, et al.
Publicado: (2021) -
A bioinformatics-to-clinic sequential approach to analysis of prostate cancer biomarkers using TCGA datasets and clinical samples: a new method for precision oncology?
por: Yoshie, Hidekazu, et al.
Publicado: (2017) -
Synthesis of artificial substrate based on inhibitor for detecting LSD1 activity
por: Ohta, Yuhei, et al.
Publicado: (2020)